Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers

被引：41

作者：

Neuhausen, S

Dunning, A

Steele, L

Yakumo, K

Hoffman, M

Szabo, C

Tee, L

Baines, C

Pharoah, P

Goldgar, D

Easton, D

机构：

[1] Int Agcy Res Canc, F-69008 Lyon, France

[2] Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92717 USA

[3] Strangeways Res Labs, Human Canc Genet Res Grp, Cambridge, England

[4] Strangeways Res Labs, Canc Res UK Genet Epidemiol Unit, Cambridge, England

[5] Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT USA

来源：

INTERNATIONAL JOURNAL OF CANCER | 2004年 / 108卷 / 03期

关键词：

D O I：

10.1002/ijc.11385

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：477 / 478

页数：2

共 12 条

[1] BREAST-CANCER RISKS IN RELATIVES OF MALE BREAST-CANCER PATIENTS [J].

ANDERSON, DE ;

BADZIOCH, MD .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (14) :1114-1117

[2] BRCA1 and BRCA2 mutations in a population-based study of male breast cancer -: art. no. R2 [J].

Basham, VM ;

Lipscombe, JM ;

Ward, JM ;

Gayther, SA ;

Ponder, BAJ ;

Easton, DF ;

Pharoah, PDP .

BREAST CANCER RESEARCH, 2002, 4 (01) :R2

[3] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].

Ford, D ;

Easton, DF ;

Stratton, M ;

Narod, S ;

Goldgar, D ;

Devilee, P ;

Bishop, DT ;

Weber, B ;

Lenoir, G ;

Chang-Claude, J ;

Sobol, H ;

Teare, MD ;

Struewing, J ;

Arason, A ;

Scherneck, S ;

Peto, J ;

Rebbeck, TR ;

Tonin, P ;

Neuhausen, S ;

Barkardottir, R ;

Eyfjord, J ;

Lynch, H ;

Ponder, BAJ ;

Gayther, SA ;

Birch, JM ;

Lindblom, A ;

Stoppa-Lyonnet, D ;

Bignon, Y ;

Borg, A ;

Hamann, U ;

Haites, N ;

Scott, RJ ;

Maugard, CM ;

Vasen, H .

AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689

[4]

Friedman LS, 1997, AM J HUM GENET, V60, P313

[5] hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response [J].

Lee, JS ;

Collins, KM ;

Brown, AL ;

Lee, CH ;

Chung, JH .

NATURE, 2000, 404 (6774) :201-204

[6]

Lee SB, 2001, CANCER RES, V61, P8062

[7] Germline BRCA2 mutations in men with breast cancer [J].

Mavraki, E ;

Gray, IC ;

Bishop, DT ;

Spurr, NK .

BRITISH JOURNAL OF CANCER, 1997, 76 (11) :1428-1431

[8] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations [J].

Meijers-Heijboer, H ;

van den Ouweland, A ;

Klijn, J ;

Wasielewski, M ;

de Snoo, A ;

Oldenburg, R ;

Hollestelle, A ;

Houben, M ;

Crepin, E ;

van Veghel-Plandsoen, M ;

Elstrodt, F ;

van Duijn, C ;

Bartels, C ;

Meijers, C ;

Schutte, M ;

McGuffog, L ;

Thompson, D ;

Easton, DF ;

Sodha, N ;

Seal, S ;

Barfoot, R ;

Mangion, J ;

Chang-Claude, J ;

Eccles, D ;

Eeles, R ;

Evans, DG ;

Houlston, R ;

Murday, V ;

Narod, S ;

Peretz, T ;

Peto, J ;

Phelan, C ;

Zhang, HX ;

Szabo, C ;

Devilee, P ;

Goldgar, D ;

Futreal, PA ;

Nathanson, KL ;

Weber, BL ;

Rahman, N ;

Stratton, MR .

NATURE GENETICS, 2002, 31 (01) :55-59

[9]

Parkin DM, 1997, IARC SCI PUBL, VVII

[10] BREAST-CANCER IN MEN - ASPECTS OF FAMILIAL AGGREGATION [J].

ROSENBLATT, KA ;

THOMAS, DB ;

MCTIERNAN, A ;

AUSTIN, MA ;

STALSBERG, H ;

STEMHAGEN, A ;

THOMPSON, WD ;

CURNEN, MGM ;

SATARIANO, W ;

AUSTIN, DF ;

ISACSON, P ;

GREENBERG, RS ;

KEY, C ;

KOLONEL, L .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (12) :849-854

← 1 2 →